Sun Pharma News
- All
- News
- Videos
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Gautam Adani Emerges As Biggest Dollar Gainer In Forbes Rich List 2024
The collective wealth of Indias 100 richest tycoons surpassed the trillion dollar milestone for the first time as more than 80 per cent of the countrys richest tycoons are now wealthier than they were a year ago
-
IIT Kanpur Professor Wins Sun Pharma Science Foundation Research Award
Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Gautam Adani Emerges As Biggest Dollar Gainer In Forbes Rich List 2024
The collective wealth of Indias 100 richest tycoons surpassed the trillion dollar milestone for the first time as more than 80 per cent of the countrys richest tycoons are now wealthier than they were a year ago
-
IIT Kanpur Professor Wins Sun Pharma Science Foundation Research Award
Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).
